CN205569345U - Celery seeds extract product softgel - Google Patents
Celery seeds extract product softgel Download PDFInfo
- Publication number
- CN205569345U CN205569345U CN201620240153.8U CN201620240153U CN205569345U CN 205569345 U CN205569345 U CN 205569345U CN 201620240153 U CN201620240153 U CN 201620240153U CN 205569345 U CN205569345 U CN 205569345U
- Authority
- CN
- China
- Prior art keywords
- capsule
- apium graveolens
- capsule shells
- glue film
- softgel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The utility model relates to a celery seeds extract product softgel, including content and capsule shell, its characterized in that, content are celery seeds extract product granule, are shading glue film and slowly -releasing layer in the capsule shell follow extroversion in proper order, the utility model provides a capsule shell difference of softgel and the capsule shell of traditional softgel, for bilayer structure, outer shading glue film plays the effect of stabilizing celery seeds extract product and softgel, and the existence on interior slowly -releasing layer makes the patient take the back, the medicine slowly releases after the skin dissolves, the extension drug effect, after the granule is collapsed in the middle setting in shading glue film and slowly -releasing layer, can quicken dissolving of outer shading glue film, make the medicine take place the effect as early as possible.
Description
Technical field
This utility model relates to capsule, particularly to a kind of Apium graveolens Linnaeus extract soft capsule.
Background technology
Celery seed, for the seed of samphire Herba Apii graveolentis Apium graveolens L., celery seed treatment arthralgia is existing century-old history in Australia, is considered Traditional Folk folk prescription, and Apium graveolens Linnaeus extract has the multiple efficacies such as uric acid resisting, blood pressure lowering, blood fat.Take and improve the bioavailability of active ingredient for convenience, often Apium graveolens Linnaeus extract is made pharmaceutical preparation, common for tablet or capsule, the general volume of tablet is bigger, taking rear infiltration rate bad, soft capsule absorbs fast, easy to carry, and such as Chinese patent application CN102048775 discloses the soft capsule of a kind of fluid composition wrapping up Apium graveolens Linnaeus extract, effective ingredient in Apium graveolens Linnaeus extract is more stable, and oral absorption is fast, good looking appearance is easily taken；But the problem caused by quickly absorbing is, the disposable high amount of drug that quickly absorbs can cause the metabolic burden of liver kidney, once takes small quantities of drugs and will cause frequent drug administration, in today of fast pace life, is very easy to forget to take medicine on time.
Utility model content
In order to solve above-mentioned technical problem, this utility model provides a kind of Apium graveolens Linnaeus extract soft capsule, and technical scheme is:
This utility model provides a kind of Apium graveolens Linnaeus extract soft capsule, and including content and capsule shells, it is characterised in that content is Apium graveolens Linnaeus extract granule, capsule shells is followed successively by shading glue film and slow release layer from outside to inside；Preferably, capsule shells is ellipsoid shaped, drops, olive-shaped or cylindrical shape；Described Apium graveolens Linnaeus extract granule is spheroidal.
Further, it is hollow structure in the middle of shading glue film and slow release layer, in hollow structure, has been filled with the disintegrate granule of disintegration；Preferably, described disintegrate granule is spheroidal.
Further, capsule shells is cylindrical shape, is made up of upper capsule shells and lower capsule shells, and lower capsule shells lateral wall is provided with at least one annular projection, and upper capsule shells medial wall is provided with the annular recess matched with annular projection.
Further, adjacent capsules shell is connected with each other by connector, it is preferable that connector is provided with cut.
Apium graveolens Linnaeus extract soft capsule provided by the utility model, capsule shells difference and the capsule shells of traditional soft capsule, for double-decker, outer layer shading glue film, play the effect of stable Apium graveolens Linnaeus extract and soft capsule, and the existence of interior slow release layer, after making patient take, after outer layer dissolves, medicine slowly discharges, and extends drug effect；After disintegrate granule is set in the middle of shading glue film with slow release layer, the dissolving of outer shading glue film can be accelerated, make medicine generating effect as early as possible.
Accompanying drawing explanation
Fig. 1. schematic diagram cuts open in the office of embodiment 1 Apium graveolens Linnaeus extract soft capsule；
Fig. 2. schematic diagram cuts open in the office of embodiment 2 Apium graveolens Linnaeus extract soft capsule；
Fig. 3. schematic diagram cuts open in the decomposition office of embodiment 3 Apium graveolens Linnaeus extract soft capsule；
Fig. 4. the connection diagram of embodiment 4 Apium graveolens Linnaeus extract soft capsule.
Detailed description of the invention
The utility model will be further described with embodiment below in conjunction with the accompanying drawings.
Embodiment 1:
As shown in Figure 1, the present embodiment provides a kind of Apium graveolens Linnaeus extract soft capsule, including content 1 and capsule shells 2, it is characterized in that, content 1 is Apium graveolens Linnaeus extract granule, capsule shells 2 is followed successively by shading glue film 101 and slow release layer 102 from outside to inside, and capsule shells 2 is chosen as ellipsoid shaped, drops, olive-shaped or cylindrical shape.
The Apium graveolens Linnaeus extract soft capsule of the present embodiment, capsule shells difference and the capsule shells of traditional soft capsule, for double-decker, outer layer shading glue film, play the effect of stable Apium graveolens Linnaeus extract and soft capsule, and the existence of interior slow release layer, after making patient take, after outer layer dissolves, medicine slowly discharges, and extends drug effect.
Embodiment 2:
As in figure 2 it is shown, the Apium graveolens Linnaeus extract soft capsule that the present embodiment is provided, it is with embodiment 1 difference, limits further, be hollow structure in the middle of shading glue film 101 and slow release layer 102, in hollow structure, be filled with the disintegrate granule 103 of disintegration.
The Apium graveolens Linnaeus extract soft capsule of the present embodiment, after patient takes, when gastric juice penetrates into shading glue film but all do not dissolved by shading glue film, after touching the disintegrate granule of hollow structure, can accelerate the dissolving of outer shading glue film, make medicine generating effect as early as possible.
Embodiment 3:
As shown in Figure 3, the Apium graveolens Linnaeus extract soft capsule that the present embodiment is provided, it is with embodiment 1 difference, limit further, capsule shells 2 is cylindrical shape, being made up of upper capsule shells 301 and lower capsule shells 302, lower capsule shells 302 lateral wall is provided with at least one annular projection 303, and upper capsule shells 301 medial wall is provided with the annular recess 304 matched with annular projection.
The Apium graveolens Linnaeus extract soft capsule of the present embodiment, separable upper capsule shells and lower capsule shells wrap up Apium graveolens Linnaeus extract jointly, half amount can be facilitated to take or infant is taken on a small quantity；After upper and lower capsule shells is improved further, simple in construction, efficiently solve the easy disengagement disconnected from each other of upper and lower capsule shells, thus cause the problem that medicine reveals.
Embodiment 4
As shown in Figure 4, the Apium graveolens Linnaeus extract soft capsule that the present embodiment is provided, it is with embodiment 1 difference, limiting further, adjacent capsules shell 2 is connected with each other by connector 3, it is preferable that connector 3 is provided with cut.It is provided with connector between adjacent independent capsules carries, storage that can be convenient and carry capsule, solve the problem that independent capsules is easily lost.
Above example is only and is described preferred implementation of the present utility model; not scope of the present utility model is defined; on the premise of without departing from this utility model design spirit; various deformation that the technical solution of the utility model is made by those of ordinary skill in the art and improvement, all should fall in the protection domain that claims of the present utility model determine.
Claims (6)
1. an Apium graveolens Linnaeus extract soft capsule, including content (1) and capsule shells (2), it is characterized in that, described content (1) is Apium graveolens Linnaeus extract granule, and described capsule shells (2) is followed successively by shading glue film (101) and slow release layer (102) from outside to inside.
2. Apium graveolens Linnaeus extract soft capsule as claimed in claim 1, it is characterized in that, it is hollow structure in the middle of described shading glue film (101) and slow release layer (102), in described hollow structure, has been filled with the disintegrate granule (103) of disintegration.
3. Apium graveolens Linnaeus extract soft capsule as claimed in claim 1, it is characterised in that described capsule shells (2) is ellipsoid shaped or cylindrical shape.
4. Apium graveolens Linnaeus extract soft capsule as claimed in claim 3, it is characterized in that, described capsule shells (2) is cylindrical shape, it is made up of upper capsule shells (301) and lower capsule shells (302), described lower capsule shells (302) lateral wall is provided with at least one annular projection (303), and described upper capsule shells (301) medial wall is provided with the annular recess (304) matched with described annular projection.
5. the Apium graveolens Linnaeus extract soft capsule as described in claim 1-4 is arbitrary, it is characterised in that be connected with each other by connector (3) between capsule shells (2).
6. Apium graveolens Linnaeus extract soft capsule as claimed in claim 5, it is characterised in that described connector (3) is provided with cut.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201620240153.8U CN205569345U (en) | 2016-03-25 | 2016-03-25 | Celery seeds extract product softgel |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201620240153.8U CN205569345U (en) | 2016-03-25 | 2016-03-25 | Celery seeds extract product softgel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN205569345U true CN205569345U (en) | 2016-09-14 |
Family
ID=56867264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201620240153.8U Active CN205569345U (en) | 2016-03-25 | 2016-03-25 | Celery seeds extract product softgel |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN205569345U (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108606124A (en) * | 2018-05-03 | 2018-10-02 | 桂林漓峰医药用品有限责任公司 | A kind of celery seed fat decreasing tea |
| CN113598356A (en) * | 2021-07-27 | 2021-11-05 | 康道生物（南通）有限公司 | Preparation process of ganoderma lucidum spore oil soft capsule |
-
2016
- 2016-03-25 CN CN201620240153.8U patent/CN205569345U/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108606124A (en) * | 2018-05-03 | 2018-10-02 | 桂林漓峰医药用品有限责任公司 | A kind of celery seed fat decreasing tea |
| CN113598356A (en) * | 2021-07-27 | 2021-11-05 | 康道生物（南通）有限公司 | Preparation process of ganoderma lucidum spore oil soft capsule |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9693964B2 (en) | Hydroxypropyl starch vacant capsules and a process for producing them | |
| US20110014268A1 (en) | Formulation for oral administration | |
| CN205569345U (en) | Celery seeds extract product softgel | |
| CN103263402A (en) | Water-drinking-free oral drug composition and preparation method thereof | |
| CN103784396A (en) | Oral ibuprofen pellet xerogel and preparation method thereof | |
| CN101564378B (en) | levocarnitine oral solution and preparation method thereof | |
| CN102631336B (en) | Freeze-drying orally disintegrating tablet with vitamin K1 composition for infants and preparation method for freeze-drying orally disintegrating tablet | |
| CN104784157A (en) | Stable Montelukast oral film preparation | |
| CN104787501A (en) | Controlled-release brewing-drinking device and method for Chinese medicine particles | |
| CN203507128U (en) | First-aid kit for rapidly grinding drugs | |
| CN104223073B (en) | A kind of food, health products or pharmaceutical composition of sleeping | |
| JP2013540726A (en) | Laxatives | |
| CN104840800A (en) | Composition of bamboo leaf flavonoid and gamma-aminobutyric acid as well as preparation method and applications thereof | |
| CN104490925A (en) | Vitamin D calcium composition chewable tablets and preparation method thereof | |
| CN103223080A (en) | Traditional Chinese medicinal composition for tranquilizing mind by nourishing the heart and preparation method thereof | |
| CN202875846U (en) | Capsule shell structure | |
| CN205181821U (en) | Compound chinese materia medica preparation of intestines and stomach | |
| CN102552401A (en) | Musk Baoxin long-acting medicine product and preparation method thereof | |
| CN218979847U (en) | Hollow capsule | |
| CN215350810U (en) | Zinc gluconate capsule | |
| CN208065476U (en) | A kind of medicinal oral hard capsule | |
| CN103830221A (en) | Applications of hydroxysafflor yellow A in preparation of medicines used for treating cardiovascular diseases | |
| CN107496510A (en) | A kind of blue or green money willow capsule and preparation method thereof | |
| US20180140526A1 (en) | Composition for hydration in solid form | |
| CN104490926A (en) | Calcium carbonate composition chewable tablet and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP03 | Change of name, title or address |
Address after: 519015 west side of the second floor of Everbright International Trade Center, 47 Haibin South Road, Jida, Zhuhai City, Guangdong Province Patentee after: Sailong Pharmaceutical Group Co.,Ltd. Address before: 519015 west side of 2nd floor, Everbright International Trade Center, No. 47, Jida Haibin South Road, Xiangzhou District, Zhuhai City, Guangdong Province Patentee before: ZHUHAI SAILONG PHARMACEUTICAL Co.,Ltd. |
|
| CP03 | Change of name, title or address |